CryoPort stock gains analyst support as BTIG reiterates Buy rating

Published on 09/18/2026 at 20:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CryoPort stock received a reiterated Buy rating from BTIG Research with a USD 25.00 price target as of September 18, 2026. The shares recently traded around USD 16.78, implying nearly 49 percent upside to the target.

CYRX, US2289031005, Illustration mit AI erstellt.

CryoPort stock (ISIN US2289031005) drew renewed attention on September 18, 2026 after BTIG Research reiterated its Buy rating and confirmed a USD 25.00 price target, signaling confidence in the company’s growth prospects in temperature-controlled logistics for life sciences.

BTIG maintains Buy rating and USD 25 target

According to MarketBeat on September 18, 2026, BTIG Research reiterated its Buy rating on CryoPort and kept its price target at USD 25.00 per share, implying an upside potential of about 48.99 percent from the previous close of USD 16.78.

As TradingView reported on September 18, 2026, the reiterated target of USD 25.00 is benchmarked against a closing price of USD 16.78 on September 17, 2026, which translates into roughly 49.0 percent potential upside if the target is reached.

MarketBeat’s analyst overview notes that seven analysts currently rate CryoPort stock as Buy, one as Hold and one as Sell, resulting in a consensus rating described as Moderate Buy and an average target price around USD 18.00, underscoring that BTIG’s USD 25.00 target sits above the broader analyst average for the stock.

Valuation and fundamentals in focus

According to GuruFocus on September 18, 2026, CryoPort stock was trading at USD 16.79 while their GF Value metric stood at USD 11.15, implying the shares were about 50.6 percent above the platform’s estimate of intrinsic value.

GuruFocus assigns CryoPort a GF Score of 67 out of 100, which the platform characterizes as a moderate level of overall company quality and potential, suggesting that while the business has solid fundamentals, the valuation premium relative to GF Value may reflect high expectations for future growth.

The same GuruFocus analysis highlights that BTIG’s maintained Buy rating and USD 25.00 price target reflects optimism about CryoPort’s long-term growth trajectory, but it also cautions that the stock’s perceived overvaluation and mixed insider activity are risk factors investors should weigh against the upside potential.

Stock price context for CryoPort

MarketBeat’s alert shows that shares of CryoPort stock opened at USD 16.78 on September 18, 2026 on Nasdaq, close to the prior closing level of USD 16.78 on September 17, 2026, so the BTIG reiteration comes at a time when the stock is trading well below the USD 25.00 target yet above the GF Value estimate of USD 11.15.

In valuation terms, the gap between the USD 16.78 to USD 16.79 trading range in mid-September 2026 and the USD 11.15 GF Value suggests that CryoPort stock is priced about USD 5.63 above that intrinsic value estimate, which corresponds to the roughly 50.6 percent premium cited by GuruFocus.

For investors, the key tension is that BTIG’s USD 25.00 target implies nearly 49 percent upside from the USD 16.78 prior close, while GuruFocus indicates the current price sits more than 50 percent above its intrinsic value estimate, presenting a clear numerical contrast between growth optimism and valuation risk.

Closing view on CryoPort stock

At around USD 16.78 to USD 16.79 per share as of September 17-18, 2026 on Nasdaq, CryoPort stock trades significantly below BTIG’s USD 25.00 target yet notably above the USD 11.15 GF Value benchmark, leaving the shares positioned between analyst upside expectations and cautionary valuation signals.